HomeAbout

TL;DR CNBC


Moderna says new Covid vaccine showed stronger immune response than current shot in study - TL;DR CNBC

Moderna says new Covid vaccine showed stronger immune response than current shot in study

Publishing timestamp: 2024-03-26 13:02:26


Summary

Moderna's new version of Covid vaccine triggers stronger immune response, potentially offering longer shelf life and easier storage. Results show higher immune response against omicron subvariants and original strain of virus. Viking Therapeutics stock jumps on weight loss pill data, Amgen entering weight loss drug market. Medicare now covers certain weight loss drugs. Moderna to present detailed analysis of trial results at investor event, highlighting pipeline including shots against flu, cancer, and other diseases.


Sentiment: POSITIVE

Tickers: PFEMRNA

Keywords: biotech and pharmaceuticalsbreaking newshealth care industrybiotechnologypfizer incsciencebusinessmoderna incpharmaceuticalsbusiness news

Source: https://www.cnbc.com/2024/03/26/moderna-says-new-covid-vaccine-showed-positive-late-stage-data.html


Developed by Leo Phan